ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Ankylosing spondylitis (AS)"

  • Abstract Number: 493 • 2012 ACR/ARHP Annual Meeting

    Effect of Infliximab On Employment Status in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis

    W. Bensen1, J. Carter Thorne2, Saeed A. Shaikh3, Maqbool K. Sheriff4, Susan M. Otawa5, Allen J. Lehman5 and Hayssam Khalil6, 1St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada, 2Southlake Regional Health Centre, Newmarket, ON, Canada, 3Medicine, McMaster University, St Catharines, ON, Canada, 4Nanaimo Regional General Hospital, Nanaimo, BC, Canada, 5Medical Affairs, Janssen Inc., Toronto, ON, Canada, 6Medical Affairs, Janssen Canada Inc, Toronto, ON, Canada

    Background/Purpose: Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are associated with significant functional impairment and work disability. In the absence of treatment, approximately 80% of…
  • Abstract Number: 2225 • 2012 ACR/ARHP Annual Meeting

    Improvement in Signs and Symptoms of Active Ankylosing Spondylitis Following Treatment with Anti-Interleukin (IL)-17A Monoclonal Antibody Secukinumab Are Paralleled by Reductions in Acute Phase Markers and  Inflammatory Markers S100A8 and A9 (Calgranulin A and B)

    Dominique L. Baeten1, Stephan Bek2, Jiawei Wei3, Arndt Brachat4, Joachim Sieper5, Paul Emery6, Jürgen Braun7, Desiree M. van der Heijde8, Iain B. McInnes9, Jacob M. van Laar10, R. Landewe11, Paul Wordsworth12, Jurgen Wollenhaupt13, Herbert Kellner14, Jacqueline E. Paramarta15, Arthur Bertolino16, Andrew Wright17 and Hueber Wolfgang2, 1Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 2Novartis Institutes for BioMedical Research, Basel, Switzerland, 3Integrated Information Sciences (IIS), Beijing Novartis Pharma Co. Ltd., Shanghai,, China, 4Novartis Pharma AG, Novartis Pharma AG, Basel, Switzerland, 5Medical Department I, Rheumatology, Charité Universitätesmedizin Berlin, Berlin, Germany, 6Medicine, Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 7Rheumazentrum Ruhrgebiet, Herne, Germany, 8Dept of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 9Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 10Newcastle University, Musculoskeletal Research Group, Newcastle, United Kingdom, 11Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 12Nuffield Orthopaedic Centre, Oxford, United Kingdom, 13Division of Reheumatology, Schoen-Klinik Hamburg-Eilbek Teaching Hospital of the University of Hamburg, Hamburg, Germany, 14Centre for Inflammatory Joint Diseases, Munich, Germany, 15Department of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 16Translational Medicine- 3rd Floor, Novartis Institutes for BioMedical Research, Basel, Switzerland, 17Novartis Pharma AG, Basel, Switzerland

    Background/Purpose: Secukinumab has shown to be well tolerated and effective in active ankylosing spondylitis (AS) patients in a proof-of-concept trial1. Briefly, at Week (Wk) 6,…
  • Abstract Number: 1383 • 2012 ACR/ARHP Annual Meeting

    The Burden of Ankylosing Spondylitis and the Cost-Effectiveness of Anti-Tumor Necrosis Factor α Agents in Romania

    Ioan Ancuta1, Catalin Codreanu2, Ruxandra Ionescu3, Magda Parvu4 and Mihai Bojinca1, 1Internal Medicine, “Dr. I. Cantacuzino” Hospital, Bucharest, Romania, 2Rheumatology, “Dr. I. Stoia” Center for Rheumatic Diseases, Bucharest, Romania, 3Internal Medicine, Clinic Hospital Sf. Maria, Bucharest, Romania, 4Internal Medicine, “N.Gh. Lupu” Clinical Hospital, Bucharest, Romania

    Background/Purpose: Ankylosing Spondylitis (AS) usually affects young males, severely impairing their quality of life. Chronic treatment of AS using anti-TNF α agents is costly and…
  • Abstract Number: 592 • 2012 ACR/ARHP Annual Meeting

    Two Novel Diagnostic Biomarkers of Cartilage Degradation and Connective Tissue Inflammation Are Predictive of Disease Progression in Ankylosing Spondylitis

    Anne C. Bay-Jensen1, Stephanie Wichuk2, Inger Byrjalsen3, Zheng Zhao4, Robert GW Lambert5, Morten Asser Karsdal6 and Walter P. Maksymowych7, 1Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 2Medicine, University of Alberta, Edmonton, AB, Canada, 3Research & Development, Nordic Bioscience, Herlev, Denmark, 4Department of Rheumatology, University of Alberta and PLA General Hospital, Beijing, PR China, Beijing, AB, China, 5Radiology, University of Alberta, Edmonton, AB, Canada, 6Nordic Bioscience A/S, Herlev, Denmark, 7Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Cartilage degradation and inflammation of synovial and connective tissue are key events in inflammatory arthropathies such as SpA. Presently there are no prognostic tools…
  • Abstract Number: 2652 • 2012 ACR/ARHP Annual Meeting

    Benefits of Aerobic Training in Patients with Ankylosing Spondylitis Are Not Coupled by Effects On Cytokines: A Randomized Controlled Trial

    Fabio Jennings1, Hilda A. Oliveira2, Marcelo C. Sousa1, Vaneska G. Cruz1, Fabio S. Lira3 and Jamil Natour1, 1Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 2Rheumatology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 3Psicobiology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil

    Background/Purpose: Ankylosing Spondylitis (AS) is a systemic inflammatory disease that causes deterioration of physical capacity. Although exercises remain essential in the treatment, the literature lacks…
  • Abstract Number: 2233 • 2012 ACR/ARHP Annual Meeting

    Assessing the Clinical and Economic Burden of U.S. Veteran Ankylosing Spondylitis Patients

    Lin Xie1, Onur Baser2, Ahong Huang3, Lu Li3, Elyse K. Fritschel3 and Li Wang4, 1Director, Health Economics & Outcomes Research, STATinMED Research, Ann Arbor, MI, 2President/Adjunct Professor of Internal Medicine, STATinMED Research/The University of Michigan, Ann Arbor, MI, 3STATinMED Research, Dallas, TX, 4Director, Analytic Research, STATinMED Research, Dallas, TX

    Background/Purpose: To examine the economic burden, demographic and clinical characteristics of ankylosing spondylitis (AS) in the U.S. veteran population. Methods:   A retrospective database analysis…
  • Abstract Number: 1384 • 2012 ACR/ARHP Annual Meeting

    The Frequency of Non-Radiographic Axial Spondyloarthritis in Relation to Symptom Duration in Patients Referred Because of Chronic Back Pain: Results From the Berlin Early Spondyloarthritis Clinic

    Denis Poddubnyy1, Henning Brandt2, Janis Vahldiek3, Inge Spiller2, In-Ho Song4, Martin Rudwaleit5 and Joachim Sieper6, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Medical Department I, Rheumatology, Charité Medical University, Campus Benjamin Franklin, Berlin, Germany, 3Charité Medical University, Campus Benjamin Franklin, Berlin, Germany, 4Medical Department I, Rheumatology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany, 5Endokrinologikum Berlin, Berlin, Germany, 6Medical Department I, Rheumatology, Charité Universitätesmedizin Berlin, Berlin, Germany

    Background/Purpose: Non-radiographic axial spondyloarthritis (nr-axSpA) and radiographic axial SpA (=ankylosing spondylitis – AS) are considered currently as two stages of axial SpA. We reported recently…
  • Abstract Number: 597 • 2012 ACR/ARHP Annual Meeting

    Investigating the Genetic Association Between ERAP1 and Spondyloarthritis

    Amir Kadi1, Brigitte Izac2, Roula Said-Nahal3, Ariane Leboime4, Kurt L. de Vlam5, Dirk Elewaut6, Gilles Chiocchia2 and Maxime A. Breban3, 1Institut Cochin - Université Paris Descartes - INSERM U1016 - CNRS (UMR 8104), Paris, France, 2Immunology and Hematology Department, Institut Cochin - INSERM U1016 - CNRS (UMR 8104), Paris, France, 3Rheumatology Division, Ambroise Paré Hospital (AP-HP), and Versailles Saint Quentin en Yvelines University, Boulogne-Billancourt, France, 4Rheumatology Division, Ambroise-Paré Hospital AP-HP, Boulogne-Billancourt, France, 5Rheumatology, University Hospitals Leuven, Leuven, Belgium, 6Rheumatology, Department of Rheumatology Ghent University Hospital, Ghent, Belgium

    Background/Purpose:  A robust association was recently identified between polymorphisms in the non-major histocompatibility complex gene ERAP1 and ankylosing spondylitis (AS) in several populations. The aim…
  • Abstract Number: 2235 • 2012 ACR/ARHP Annual Meeting

    How Important Is the Assessment of ASDAS in the Long-Term Evaluation of Disease Activity in Ankylosing Spondylitis? A Comparison with Currently Used Clinical Parameters

    Xenofon Baraliakos1, Claudia Fritz2, Joachim Listing3, Hildrun Haibel4, Joachim Sieper5 and Jürgen Braun6, 1Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, 2German Rheumatism Research Centre, Berlin, Germany, 3German Rheumatism Research Center, Berlin, Germany, 4Medical Department I, Rheumatology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany, 5Rheumatology, Charité Universitätesmedizin Berlin, Berlin, Germany, 6PsAID taskforce, EULAR, Zurich, Switzerland

    Background/Purpose: Measures for disease activity (BASDAI) or response to therapy (ASAS partial remission (PR)) are widely used in the assessment of patients with ankylosing spondylitis…
  • Abstract Number: 1385 • 2012 ACR/ARHP Annual Meeting

    Increased Body Mass Index in Ankylosing Spondylitis Is Associated with a Greater Burden of Symptoms and Poor Perceptions of the Benefits of Exercise

    Laura J. Durcan1, Fiona Wilson2, Richard Conway1, Gaye Cunnane3 and Finbar (Barry) D. O'Shea4, 1Rheumatology, St James's Hospital, Dublin, Ireland, 2Physiotherapy, Trinity College, Dublin, Ireland, 3Dept of Rheumatology, St James's Hospital, Dublin, Ireland, 4Rheumatology Dept, St James's Hospital, Dublin, Ireland

    Background/Purpose: In Ankylosing Spondylitis (AS) the effect of obesity on disease characteristics and exercise perceptions is unknown. Exercise is an essential component in the management…
  • Abstract Number: 598 • 2012 ACR/ARHP Annual Meeting

    The Non-Synonymous Polymorphism IL23R Arg381Gln Is Associated with Ankylosis in Spondyloarthritis

    Amir Kadi1, Félicie Costantino2, Brigitte Izac3, Ariane Leboime4, Roula Said-Nahal5, Gilles Chiocchia3 and Maxime A. Breban5, 1Institut Cochin - Université Paris Descartes - INSERM U1016 - CNRS (UMR 8104), Paris, France, 2INSERM U987, Faculté des Sciences de la Santé Simone Veil, Montigny-le-Bretonneux, France, 3Immunology and Hematology Department, Institut Cochin - INSERM U1016 - CNRS (UMR 8104), Paris, France, 4Rheumatology Division, Ambroise-Paré Hospital AP-HP, Boulogne-Billancourt, France, 5Rheumatology Division, Ambroise Paré Hospital (AP-HP), and Versailles Saint Quentin en Yvelines University, Boulogne-Billancourt, France

    Background/Purpose: Spondyloarthritis (SpA) is a group of articular disorders sharing genetic background. Single-nucleotide polymorphisms (SNP) of the interleukin 23 receptor (IL23R) gene have been reproducibly…
  • Abstract Number: 2213 • 2012 ACR/ARHP Annual Meeting

    Ankylosing Spondylitis Is Strongly Related to Clinical Spine Fractures Independently of Drugs Use: A Register-Based Case-Control Study

    Daniel Prieto-Alhambra1, Juan Muñoz-Ortego2, Cyrus Cooper3, Adolfo Díez-Pérez4 and Peter Vestergaard5, 1Internal Medicine; Primary Care; NDORMS Dept; MRC Lifecourse Epidemiology Unit, URFOA-IMIM, Parc de Salut Mar; Idiap Jordi Gol; University of Oxford; University of Southampton, Barcelona, Spain, 2Rheumatology, Hospital Sagrat Cor, Barcelona (Spain), Spain, 3NDORMS; MRC Lifecourse Epidemiology Unit, University of Oxford; Southampton General Hospital, Southampton, United Kingdom, 4Internal Medicine, Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Barcelona; and RETICEF, ISCIII Madrid; Spain, Barcelona, Spain, 5Endocrinology and Internal Medicine (MEA), Aarhus University Hospital THG, Aarhus (Denmark), Aarhus, Denmark

    TITLE: "Ankylosing Spondylitis is strongly related to clinical spine fractures independently of drugs use: a register-based case-control study."Background/Purpose: Ankylosing Spondylitis (AS) is associated not only…
  • Abstract Number: 1356 • 2012 ACR/ARHP Annual Meeting

    Gender Differences Among Spondylitis Associated with Psoriasis, Inflammatory Bowel Disease and Primary Ankylosing Spondylitis

    Margarita Landi1, Hernan Maldonado-Ficco2, Jose A. Maldonado-Cocco2, Gustavo Citera3, Pablo Arturi2, Percival Sampaio-Barros4, Diana Flores5, Ruben Burgos-Vargas6, Helena Santos7, Jose Chavez-Corrales8, Daniel Palleiro9, Miguel A. Gutierrez10, Elsa Vieira-Sousa11, Fernando Pimentel-Santos12, Sergio O. Paira13, Alberto Berman Sr.14, Janitzia Vazquez-Mellado15, Eduardo Collantes-Estevez16 and On behalf of RESPONDIA Group17, 1Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina, 2Rheumatology, Instituto de Rehabilitacion Psicofisica and Fundacion Reumatologica Argentina, Buenos Aires, Argentina, 3Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 4Rheumatology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil, 5Rheumatology, Hospital Universitario, Monterrey, Mexico, 6Rheumatology, Hospital General de Mexico, Mexico DF, Mexico, 7Rheumatology, Instituto Português de Reumatologia, Lisboa, Portugal, 8Rheumatology, Hospital Nacional E. Rebagliti-ESSALUD, Lima, Peru, 9Rheumatology, Instituto Nacional de Reumatologia, Montevideo, Uruguay, 10Rheumatology and Inmunology, Pontificia Universidad Catolica de Chile, Santiago, Chile, 11Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, 12Rheumatology, Centro Hospitalar de Lisboa Ocidental, Hospital Egas Moniz, Lisboa, Portugal, 13Hospital Jose María Cullen, Santa Fe SFE S3000BFP, Argentina, 14Internal Medicine, Hospital Padilla, Tucuman, Argentina, 15Rheumatology, Hospital General de Mexico, Mexico city, Mexico, 16Depatamento de Medicina, IMIBIC-Reina Sofia Hospital, Cordoba 14012, Spain, 17Buenos Aires

    Background/Purpose: Differences regarding gender in primary Ankylosing Spondylitis are well known. However, there is less evidence regarding Spondylitis Associated with Psoriasis and that associated with…
  • Abstract Number: 599 • 2012 ACR/ARHP Annual Meeting

    LIGHT (TNFSF14), Cathepsin K, DKK-1 and Sclerostin in Ankylosing Spondylitis: Osteoclast/OSTEOBLAST  Imbalance Unrelated to Disease Activity and Effect of ANTI-TNFα Treatment On the WNT/β Catenin Pathway

    Alberto Cauli1, Grazia Dessole1, Giovanni Porru1, Matteo Piga1, Alessandra Vacca2, Valentina Ibba1, Pietro Garau1 and Alessandro Mathieu1, 1Unit and Chair of Rheumatology, University Hospital of Cagliari, Cagliari, Italy, 2Rheumatology Unit - Medical Sciences, University of Cagliari, Cagliari, Italy

    Background/Purpose: Ankylosing Spondylitis (AS) is an inflammatory arthritis characterized by erosions and new bone formation. These processes appear to be related by the fine balance…
  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology